Thirty Day Resource Utilization after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

被引：0
|
作者：
Shah, Gunjan L. [1 ]
Park, Jae [2 ]
Sauter, Craig S. [1 ]
Duck, Elaine [3 ]
Halton, Elizabeth [4 ]
Batlevi, Connie W. [5 ]
Palomba, M. Lia [5 ]
Younes, Anas [5 ]
Geyer, Mark B. [2 ]
Smith, Eric [6 ]
Mailankody, Sham [6 ]
Mead, Elena [7 ]
Santomasso, Bianca [8 ]
Perales, Miguel-Angel [9 ]
Sabbatini, Paul [10 ]
Giralt, Sergio A. [9 ]
Brentjens, Renier [2 ]
Bach, Peter B. [11 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Managed Care Outcomes Anal, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, 1275 York Ave, New York, NY 10021 USA
[8] Mem Sloan Kettering Canc Ctr, Dept Neurol, Brain Tumor Serv, 1275 York Ave, New York, NY 10021 USA
[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[10] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[11] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
48
引用
收藏
页数：2
相关论文
共 50 条
  • [21] RESOURCE UTILIZATION WITHIN 30 DAYS OF CAR T CELLS FOR HEMATOLOGIC MALIGNANCIES
    Shah, G.
    Park, J.
    Sauter, C.
    Duck, E.
    Halton, E.
    Batlevi, C.
    Palomba, M. L.
    Younes, A.
    Geyer, M.
    Smith, E.
    Santomasso, B.
    Perales, M. A.
    Sabatini, P.
    Giralt, S.
    Brenjtens, R.
    Bach, P. B.
    VALUE IN HEALTH, 2019, 22 : S38 - S38
  • [22] Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
    Wenjing Luo
    Chenggong Li
    Yinqiang Zhang
    Mengyi Du
    Haiming Kou
    Cong Lu
    Heng Mei
    Yu Hu
    BMC Cancer, 22
  • [23] Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
    Luo, Wenjing
    Li, Chenggong
    Zhang, Yinqiang
    Du, Mengyi
    Kou, Haiming
    Lu, Cong
    Mei, Heng
    Hu, Yu
    BMC CANCER, 2022, 22 (01)
  • [24] Decreased Neuroprotective Analytes on Day of Infusion of Chimeric Antigen Receptor (Car) T Cells are Associated with Neurotoxicity
    Lakkaraja, Madhavi
    Hosszu, Kinga
    McAvoy, Devin
    Mauguen, Audrey
    Purdon, Terence J.
    Khakoo, Yasmin
    Santomasso, Bianca D.
    Riviere, Isabelle
    Sadelain, Michele
    Curran, Kevin J.
    Park, Jae H.
    Brentjens, Renier J.
    Boelens, Jaap Jan
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 40 - 41
  • [25] Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies
    Abbasi, Samane
    Totmaj, Milad Asghari
    Abbasi, Masoumeh
    Hajazimian, Saba
    Goleij, Pouya
    Behroozi, Javad
    Shademan, Behrouz
    Isazadeh, Alireza
    Baradaran, Behzad
    CANCER MEDICINE, 2023, 12 (07): : 7844 - 7858
  • [26] Chimeric Antigen Receptor T Cell Therapy for γδ T Cell Malignancies
    Wawrzyniecka, Patrycja A.
    Pule, Martin A.
    Maciocia, Paul M.
    MOLECULAR THERAPY, 2019, 27 (04) : 267 - 268
  • [27] The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies
    Nagle, Sarah J.
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    CANCER JOURNAL, 2016, 22 (01): : 27 - 33
  • [28] Effects of Cannabidiol on the Functions of Chimeric Antigen Receptor T Cells in Hematologic Malignancies
    Chantarat, Natthida
    Pe, Kristine Cate
    Suppipat, Koramit
    Vimolmangkang, Sornkanok
    Tawinwung, Supannikar
    CANNABIS AND CANNABINOID RESEARCH, 2024, 9 (03) : 819 - 829
  • [29] At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies
    Oluwole, Olalekan O.
    Davila, Marco L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1265 - 1272
  • [30] Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
    Chen, Long
    Chen, Fukun
    Niu, Huatao
    Li, Jindan
    Pu, Yongzhu
    Yang, Conghui
    Wang, Yue
    Huang, Rong
    Li, Ke
    Lei, Yujie
    Huang, Yunchao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345